176 results
Page 4 of 9
8-K
EX-99.1
0mh4aso 6r95
2 Nov 20
Karyopharm Reports Third Quarter 2020 Financial Results and Highlights Recent Company Progress
4:11pm
8-K
EX-10.1
7gmv01
25 Sep 20
Departure of Directors or Certain Officers
9:22am
8-K
EX-10.3
murfrs0kux2k q3
31 Aug 20
Departure of Directors or Certain Officers
4:36pm
8-K
EX-99.1
b16tbb95o0clka2ou
4 Aug 20
Karyopharm Reports Second Quarter 2020 Financial Results and Highlights Recent Company Progress
7:13am
424B5
ecd5d6frfbhu0
5 May 20
Prospectus supplement for primary offering
5:05pm
8-K
EX-1.1
zxq m146ohjb0d2
4 Mar 20
Karyopharm Therapeutics Announces Pricing of Public Offering of Common Stock
4:22pm
424B5
kavk4ad
4 Mar 20
Prospectus supplement for primary offering
4:15pm
424B5
737vwkp533 cnsug
2 Mar 20
Prospectus supplement for primary offering
4:21pm
S-3ASR
EX-4.2
fdbp9mpl
26 Feb 20
Automatic shelf registration
8:35am
S-3ASR
EX-4.1
1q4kmn21wsx4o
26 Feb 20
Automatic shelf registration
8:35am
S-3ASR
EX-4.3
3udam5mg
26 Feb 20
Automatic shelf registration
8:35am
S-3ASR
EX-4.4
g2m4k f6ns6ntxmq9ckk
26 Feb 20
Automatic shelf registration
8:35am
S-3ASR
z3u3fo
26 Feb 20
Automatic shelf registration
8:35am
8-K
EX-99.1
556rjl90s
13 Feb 20
Karyopharm Reports Fourth Quarter and Full Year 2019 Financial Results and Highlights Recent Company Progress
7:09am